RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Carcinoma gastrico e infezione da Helicobacter pylori: importanza del genotipo, delle attività enzimatiche e del proteoma batterici e di fattori ospite-correlati, quali il polimorfismo genetico delle citochine infiammatorie e dei perossisomi e l'espressione di oncogeni, geni oncosoppressori e molecole d'adesione.
• 2 - Meccanismi di leucemogenesi e terapia target nelle sindromi Mielodisplastiche e nelle Leucemie Acute Mieloidi
• 3 - Infezioni e remodeling vascolare.
• 4 - Basi genetiche e molecolari della patogenicità batterica
• 5 - Studio sui correlati biologici e clinici degli infarti cerebrali silenti
• 6 - Strategie di sopravvivenza dei batteri patogeni in risposta alle condizioni di stress nei siti anatomici dell'ospite: aspetti biologici, patogenetici e diagnostici
• 7 - Rapporto ospite parassita nelle infezioni da clamidie e spirochete: immunità naturale e metabolismo lipidico studiati con tecniche convenzionali e con DNA microarray
• 8 - Meccanismi patogenetici e manifestazioni cliniche della broncopneumopatia cronica ostruttiva
• 9 - Ruolo dell'FGFR2 e di altri cofattori nell'etiopatogenesi di tumori epiteliali.
• 10 - L'apoptosi nei processi immunitari ed infiammatori: caratterizzazione di meccanismi molecolari e cellulari finalizzata a interventi terapeutici innovativi.

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • MICROBIOLOGIA E MICROBIOLOGIA CLINICA
  • MEDICINA INTERNA
  • SCIENZE TECNICHE DIETETICHE APPLICATE

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]

Classificazione geografica

• Regione: Lombardia

Bibliografia

Papanas N et al. Peripheral arterial occlusive disease as a predictor of the extent of coronary atherosclerosis in patients with coronary artery disease with and without diabetes mellitus. J Int Med Res. 2004. 32: 422-8
Kannel WB et al. Serum lipid fractions and risk of coronary heart disease. The Framingham study.Minn Med. 1969. 52:1225-30.
Kannel WB et al. Intermittent claudication. Incidence in the Framingham Study. Circulation. 1970. 41:875-83.
Flex A et al. The 174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg. 2002. 24:264-8
Gaetani E et al. The K469E polymorphism of the ICAM-1 gene is a risk factor for peripheral arterial occlusive disease. Blood Coagulation and Fibrinolisis. 2002. 13: 483-8
Ramirez JA. The Chlamydia pmenumoniae. Atherosclerosis Study Group. Isolation of Chlamydia pmenumoniae from the coronary of a patients with coronary atherosclerosis. An Int Med 1996. 125:979-82
Patel P et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995. 311:711-4
Chiu B et al. Chlamidya pneumoniae, cytomegalovirus and herpes simplex virus in atherosclerotic plaque of the carotid artery. Circulation. 1997. 96: 2144-8
Roivanen M et al. Infection, inflammation and the risk of coronary heart disease. Circulation. 2000. 101:252-7
Wang SP et al. Immunological relationship between genital TRIC, Lymphogranuloma venereum, and related organism in a new microtiter indirect immunofluoresce test. Am J Ophtalmol. 1970. 70:367-74
Blasi F et al. A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years age. Chest. 1997. 112:9-12
Saikku P et al. Serological evidence of an association of a novel Chlamydia TWAR with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988. 2: 983-6
Gaydos CA et al. Replication of Chalamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 1996;64:1614-20
Kol A et al. Chlamydia and human heat schock protein 60s activate human vascular endothelium, smooth muscle cells and macrophages. J Clin Invest. 1999. 103: 571-7.
Libby P et al. Role of infectious agent in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation. 1997. 96:4095-103
Heinemann M et al. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocyte line cell. Infect Immun. 1996. 64:4872-5
Kaukoranta Tolvanen SS et al. Growth of Chlamydia pneumoniae in cultured human blood mononuclear cells and induction of cytokine response. Microb Pathog. 1996. 21:215-21
de Maat MP et al. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. Atherosclerosis. 1996.121:185-9
Valtonen VV. Infection as a risk for infarction and atherosclerosis. Ann Med. 1991. 23:539-43
Patel P et al. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet 1994. 343:1634-5
Mendall MA et al. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996. 312:1061-5
Fryer RH et al. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Invest Med. 1997. 45:168-74
Lopz-Virella MF. Interaction between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease. Eur Heart J. 1993. 14:118-24
Ross R. Atherosclerosis- an inflammatory disease. N Engl J Med. 1999. 340:115-126
Shor A et al. Detection of Chalmydia pneumoniae in coronary fatty streaks and atheromatous plaque. S Afr Med J. 1992. 82:158-61
Kuo CC et al. Detection o f Chlanydia pneumoniae in aortic lesion of atherosclerosis by immunocytochemical stain. Arteriosclerosis and Thrombosis. 1993.13:1501-4
Ong G et al. Detection and widespread distibution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol. 1996. 49:102-6
Saikku P et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992. 116:273-7
Mendall MA et al. Chlamydia pneumoniae: risk factors for seropositivity and association with chronic coronary heart disease. Circulation. 1993. 87:1130-4
Shimada K et al. High prevalence of seropositivity for antibodies to Chlamydia-specif lipopolysaccharide in patients with acute coronary syndrome. J Cardiovasc Risk. 2000. 7:209-13
Aronow WS et al. Prevalence of coexistence of coronary artery disease, peripheral arterial disease and atherotrombotic barin infarction in man and women <62 years age. Am J Cardiol. 1994. 74: 64-5
Newman AB et al. Ankle-arm index as a risk marker of atherosclerosis in the Cardiovascular Health Study. Circulation. 1993. 88: 837-45
CAPRIE Sterring Committee. A randomized, blinded, trial of clorpidogel versus asprin in patients at risk of ischemic events (CAPRIE). Lancet. 1996. 41:1329-39
Gerdes VE et al. Chlamydial LPS antibodies, intima–media thickness and ischemic events in patient with established atherosclerosis. Atherosclerosis. 2003. 167:65-71
Krayenbuehl PA et al. Progression of peripheral arterial occlusive disease is associated with Chlamydia pneumoniae seropositivity and can be inhibited by antibiotic treatment. Atherosclerosis 2005. 179: 103-10
Danesh J et al. Chronic infections and coronary heart disease: is there a link? Lancet 1997. 350: 430-6.
Leinonen M et al. Infections and atherosclerosis. Scand Cardiovasc J. 2000. 34: 12-20
Kiechl S et al. Chronic infections and the risk of carotid atherosclerosis. Prospective results from large population study. Circulation. 2001. 103: 1064-70
Anzini A et al. Chlamydia pneumoniae infection in young stroke patients: a case-control study. J Microbiol Methods. 2004. 11: 321-7
Kwon TW et al. Detection of enterovirus, cytomegalovirus, and Chlamydia pneumoniae in atheromas. J Microbiol. 2004. 42: 299-304
Campbell LE et al. Chlamydia pneumoniae - an infectious risk factor for atherosclerosis? Nature Review Microbiology. 2004. 2: 23-32
Belland RJ et al. Chlamydia pneumoniae and atherosclerosis. Cell Microbiol. 2004. 6: 117-27
Suerbaum et al. Helicobacter pylori infection. N. Engl. J. Med. 2002. 347: 539-47
Reyrat JM et al. Towards deciphering the Helicobacter pylori cytotoxin. Mol Microbiol. 1999. 34: 197-204
Gunn MS et al. Significant association of CagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart. 2000. 84: 267-71
Dore PM et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori DNA in atherosclerosis plaques. Digestive Diseases and Sciences. 2003. 48: 945-51.
Epstein SE et al. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol. 2000. 20: 1417-20
Liuba P et al. Co-infection with Chlamydia pneumoniae and Helicobacter pylori results in vascular dysfunction and enhanced VCAM-1 expression in ApoE-knokout mice. J Vasc Res. 2003. 40: 115-22
Bloemenkamp D G M et al. Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and risk of peripheral arterial disease in young women. Atherosclerosis. 2002. 163: 149-56
Schumacher A et al. Does Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans?. Clin Microbiol Infect 2002. 8: 654-61
Chmiela M et al. A link between Helicobacter pylori and/or Chlamydia spp. infections and atherosclerosis. FEMS Immunology and Medical Microbiology. 2002. 36: 187-92
Wilson W J et al. Sequence-specific identification of 18 pathogenic microorganisms using microarray technology. Mol Cell Probes. 2002. 16: 119-27
Kato-Maeda M et al. Microarray analysis of pathogens and their interaction with hosts. Cell Microbiol. 2001. 3: 713-9

Parole Chiave

CHLAMYDIA PNEUMONIAE; HELICOBACTER PYLORI; ATEROSCLEROSI; INFIAMMAZIONE; INFEZIONE; ARTERIOPATIE PERIFERICHE; MICROARRAY; ESPRESSIONE GENICA; STRESS OSSIDATIVO